 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
# ~: u2 k1 q5 _9 [4 l `1 A2 E, K
+ B& c) D" G9 N" T$ N% ]3 {EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.# h; Q: H# e0 n( m- I
6 d/ Y0 r. z* \' O3 o- L+ f; [9 WBY THE EDMONTON JOURNAL FEBRUARY 16, 2007$ D9 X) W) g% x# s$ T% E7 v* }
2 m! |- q+ c( ~ 6 l7 v$ m6 s2 w: u4 M3 M
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
+ L8 |! Z. z: K# X! E
4 V, ?! s9 a5 r3 q; i" f2 h$ h0 XThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
9 Z+ ?% `( Q6 ]+ r" R9 o1 X) i
: j' ~& Y( n3 r: l% a2 S( nThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product." N- f" p+ c; m0 o' j3 v' d. [
* m. B! r0 M4 e: EIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
; `- T: x) [( t0 v$ a$ q' ~* B3 I; A
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.7 g8 C/ x" j* f9 z
) h1 n8 F) l5 \"As a scientist, it's one of the highlights of my CAREER," Shan said.% M' W' q6 a2 ?- b+ }) t Z# D A: D
3 y3 ~$ L/ H" N2 `7 g
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
% C. z$ w, l# ^* \2 y/ E2 q) t5 E; z. }1 Y- o! R
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.) D2 S8 T8 i/ E6 N$ C4 X
2 e0 ~8 m! `2 ]2 K4 h9 @* `Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.3 k Q0 G+ o# Q) Y5 U- s% h' G o
. N% i/ s' C4 o, L2 C" c& U6 VThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
- a# \# }6 G5 L0 [
2 m1 v% w; G9 e9 \' i* v, i! p, i6 A% K8 t& ?2 X4 L
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
